Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AxoGen Inc AXGN

Technology Scientific & Technical Instruments
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.


NDAQ:AXGN - Post by User

AxoGen Inc
Bullboard Posts
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Jan 24, 2024 7:38am
103 Views
Post# 35842408

AXOGEN: REPAIRING LIVES OF PATIENTS WITH PERIPHERAL NERVE IN

AXOGEN: REPAIRING LIVES OF PATIENTS WITH PERIPHERAL NERVE IN
$AXGN

Excited to share an article about  Axogen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries.

For Q3 FY23, the Company's revenue was $41.3 million, an increase of approximately 12% over Q3 FY22. For FY23, revenue guidance is in the range of $154 million to $159 million, which represents annual growth of 11% - 15% and a gross margin of 80%. 

The Company operates in the nerve industry, with a market opportunity of more than $2.7 billion. Since 2016, it has grown at a CAGR of 22%. It seems that Axogen will continue on this upward trajectory, making it an interesting watch.

Read on to know more:
https://www.aviseanalytics.com/axogen-repairing-lives-of-patients-with-peripheral-nerve-injuries/
 
 
 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities